New Key Statistics Module, Z-Score and F-Score
SZSE:300347 Key Ratios
Market Cap ¥ M | 38,518.86 |
Enterprise Value ¥ M | 34,716.82 |
P/E(ttm) | 24.42 |
PE Ratio without NRI | 27.16 |
Forward PE Ratio | 19.82 |
Price/Book | 1.95 |
Price/Sales | 5.71 |
Price/Free Cash Flow | 44.62 |
Price/Owner Earnings | 29.12 |
Payout Ratio % | 0.31 |
Revenue (TTM) ¥ M | 7,239.00 |
EPS (TTM) ¥ | 1.95 |
Beneish M-Score | -2.26 |
10-y EBITDA Growth Rate % | 41.00 |
5-y EBITDA Growth Rate % | 30.20 |
y-y EBITDA Growth Rate % | -4.30 |
EV-to-EBIT | 13.76 |
EV-to-EBITDA | 13.76 |
PEG | 0.90 |
Shares Outstanding M | 864.95 |
Net Margin (%) | 23.36 |
Operating Margin % | 23.08 |
Pre-tax Margin (%) | 30.66 |
Quick Ratio | 2.61 |
Current Ratio | 2.61 |
ROA % (ttm) | 5.73 |
ROE % (ttm) | 8.14 |
ROIC % (ttm) | 6.66 |
Dividend Yield % | 1.19 |
Altman Z-Score | 5.37 |
SZSE:300347 Number of Guru Trades
SZSE:300347 Volume of Guru Trades
Gurus Latest Trades with SZSE:300347
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300347 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hangzhou Tigermed Consulting Co Ltd Insider Transactions
No Available Data